ALIGOS THERAPEUTICS INC (ALGS) Stock Balance Sheet
USA - NASDAQ:ALGS - US01626L2043 - Common Stock
7.07 USD
-0.03 (-0.42%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 18.66M | 37.00M | 135.70M | 81.30M | 186.80M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 104.28M | 19.94M | 0 | 44.50M | 3.90M | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 5.00M | 5.20M | 5.38M | 7.70M | 13.70M | |||
| Total Current Assets | 127.94M | 62.14M | 141.08M | 133.50M | 204.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.12M | 7.33M | 9.82M | 12.50M | 15.00M | |||
| Investments And Advances | null | null | null | 0 | 15.10M | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 640.00K | 627.00K | 625.00K | 600.00K | 900.00K | |||
| Total Non-Current Assets | 6.76M | 7.95M | 10.44M | 13.20M | 31.00M | |||
| TOTAL ASSETS | 134.71M | 70.09M | 151.53M | 146.70M | 235.40M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 38.00K | 36.00K | 10.00K | 100.00K | 100.00K | |||
| Accrued Expenses | 12.96M | 16.31M | 17.05M | 17.50M | 26.70M | |||
| Accounts Payable | 3.94M | 2.57M | 2.52M | 4.70M | 3.00M | |||
| Other Current Liabilities | 3.33M | 2.82M | 4.33M | 10.70M | 9.20M | |||
| Total Current Liabilities | 20.27M | 21.74M | 23.91M | 33.10M | 39.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 122.00K | 122.00K | 231.00K | 200.00K | 400.00K | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 12.45M | 77.21M | 35.31M | 9.40M | 11.30M | |||
| Total Non-Current Liabilities | 12.58M | 77.33M | 35.54M | 9.70M | 11.60M | |||
| TOTAL LIABILITIES | 32.84M | 99.07M | 59.45M | 42.80M | 50.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -590.78M | -618.01M | -486.80M | -399.10M | -303.10M | |||
| Additional Paid In Capital | 692.22M | 588.58M | 578.33M | 502.60M | 487.30M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 9.00K | 8.00K | 7.00K | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 420.00K | 451.00K | 545.00K | 400.00K | 500.00K | |||
| Shares Outstanding | 6.95M | 3.99M | 6.00M | 42.90M | 42.70M | |||
| Tangible Book Value per Share | 14.6543 | -7.2648 | 15.3585 | 2.4219 | 4.3255 | |||
| Total Shareholders' Equity | 101.87M | -28.97M | 92.08M | 103.90M | 184.70M | |||
| TOTAL LIABILITIES AND EQUITY | 134.71M | 70.09M | 151.53M | 146.70M | 235.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 6.31 | 2.86 | 5.90 | 4.03 | 5.24 | |||
| Return On Assets (ROA) | -55.07% | -187.19% | -57.86% | -65.47% | -54.52% | |||
| Return On Equity (ROE) | -72.83% | N/A | -95.22% | -92.44% | -69.48% | |||
All data in USD , ROIC based on taxRate of 0.21